What is ArriVent BioPharma, Inc.'s return on equity?

ArriVent BioPharma, Inc. (AVBP) reported return on equity of -55.2% in Q1 2026.

How has ArriVent BioPharma, Inc.'s return on equity changed year-over-year?

ArriVent BioPharma, Inc.'s return on equity decreased by 12.6% year-over-year, from -49% to -55.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

ArriVent BioPharma, Inc. AVBP Return on equity

Return on equity at other companies

Johnson & JohnsonJNJ

26.4%-3.0pp

Syndax PharmaceuticalsSNDX

-189.5%-8,509pp

Nuvation BioNUVB

-39.5%-15.8pp

ImmunomeIMNM

-50.1%-10.8pp

Arcus BiosciencesRCUS

-70%+8.4pp

Erasca, Inc.ERAS

-69.9%+77.1pp

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Calculated from ArriVent BioPharma, Inc.’s reported figures.

net income/total stockholders equity=-55.2%

Based on trailing twelve months.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s return on equity?: ArriVent BioPharma, Inc. (AVBP) reported return on equity of -55.2% in Q1 2026.
How has ArriVent BioPharma, Inc.'s return on equity changed year-over-year?: ArriVent BioPharma, Inc.'s return on equity decreased by 12.6% year-over-year, from -49% to -55.2%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.